Related Experiment Video
Updated: Jun 22, 2026

05:06
A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis
Published on: October 24, 2015
Skin metastasis from hepatocarcinoma
Mario Magaña1, Luz-Maria Gomez
1Service of Dermatology, Hospital General de México and School of Medicine, Universidad Nacional Autónoma de México (UNAM), Mexico City, México. dermatopatología@hotmail.com
The American Journal of Dermatopathology
|June 23, 2009
Summary
Cutaneous metastases, a rare sign of internal cancer, can manifest as skin lesions. Hepatocellular carcinoma rarely spreads to the skin, sometimes appearing as pyogenic granuloma.
Area of Science:
- Oncology
- Dermatology
- Hepatology
Background:
- Cutaneous metastases are secondary malignant skin tumors originating from a primary internal neoplasm.
- Hepatocellular carcinoma (HCC) is a primary liver cancer with rare instances of skin metastasis.
- Skin involvement from HCC can present with diverse morphologies, including papules, nodules, and masses.
Observation:
- A 41-year-old male patient with known hepatocellular carcinoma and hepatic cirrhosis developed skin metastases.
- The patient's metastatic disease manifested clinically as a pyogenic granuloma-like lesion.
- This presentation highlights the varied clinical appearance of cutaneous HCC.
Findings:
- Hepatocellular carcinoma is an uncommon cause of secondary skin cancer.
- Metastatic HCC to the skin can mimic benign vascular tumors like pyogenic granuloma.
- A review of 38 literature cases and the current case demonstrates the protean nature of skin involvement in HCC.
Implications:
- Recognition of rare cutaneous metastases from hepatocellular carcinoma is crucial for timely diagnosis and management.
- Dermatologists and oncologists should consider HCC in the differential diagnosis of unusual skin lesions, especially in patients with liver disease.
- This review provides a practical overview for clinicians managing patients with potential skin involvement from hepatocellular carcinoma.
Related Concept Videos
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

